Obstetrics & Gynecology Doctors in San Pablo, CA Accepting Medicare

3 Obstetrics & Gynecology doctors found. Showing 1 - 3

Marvelle Tekola Maloney, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 100 San Pablo Towne Center A Ste 100, Ste 100, San Pablo, CA 94806 Phone: 510-724-9110

Matthew Steven Fore, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 100a San Pablo Towne Ctr, San Pablo, CA 94806 Phone: 510-893-1700

Kwang Poung Chiu, M.D. Obstetrics & Gynecology - Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2089 Vale Rd, Suit 24, San Pablo, CA 94806 Phone: 510-367-3833    Fax: 510-235-9907

News Archive

A sweet pill to swallow: oral nucleoside analog of Remdesivir improved SARS-CoV-2 pathogenesis in mice

A new study focused on in vitro antiviral activity in various cell models and in vivo therapeutic efficacy of oral GS-621763 in a mouse model of SARS-CoV-2 pathogenesis.

Research shows infants experience automatic calming reaction when carried by their mothers

There is a very good reason mothers often carry their crying babies, pacing the floor, to help them calm down. New research published in the Cell Press journal Current Biology on April 18 shows that infants experience an automatic calming reaction upon being carried, whether they are mouse or human babies.

Positive results from POZEN's PA32540 Phase 3 trials presented at AHA Scientific Sessions 2012

POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, presented positive results from two pivotal Phase 3 clinical trials of the investigational product, PA32540, at The American Heart Association (AHA) Scientific Sessions 2012, as Poster #12057: Treatment Continuation and Cardiovascular Safety of Antiplatelet Therapy with PA32540, A Tablet with Enteric-Coated Aspirin and Immediate-Release Omeprazole: Results of Two 6-Month, Phase 3 Studies.

Polaris initiates ADI-PEG 20 Phase 3 trial in hepatocellular carcinoma

Polaris Group today announced that it has dosed the first patient in a pivotal Phase 3 clinical trial evaluating its lead cancer therapeutic, pegylated arginine deiminase (ADI-PEG 20), in hepatocellular carcinoma (HCC) patients.

Washington, D.C., to offer caremark Rx discount cards to all residents

Washington, D.C., Mayor Anthony Williams on Wednesday announced a program called DC Rx that will provide prescription drug discount cards at no cost to residents, the Washington Post reports (Silverman, Washington Post, 10/19).

Read more Medical News

› Verified 6 days ago